Catalyst Wire Dossier Catalyst Wire Dossier

Salmeterol inhalation powder

salmeterol · Boehringer Ingelheim
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Salmeterol inhalation powder, covering 2014-09-12 to 2014-09-12. Get the full timeline:

Most recent: Clinical Trial Update: Salmeterol Inhalation Powder Administered as the Xinafoate Salt From Hard Polyethylene Capsules Via the HandiHaler® 2, and Serevent® Diskus® in Patients With Chronic Obstructive Pulmonary Disease (COPD) [Phase 2]

See pricing